Page last updated: 2024-10-20

uracil and Local Neoplasm Recurrence

uracil has been researched along with Local Neoplasm Recurrence in 145 studies

2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder

Research Excerpts

ExcerptRelevanceReference
"Adjuvant therapy using a combination of oral protein-bound polysaccharide K and tegafur/uracil is highly effective in preventing the recurrence of colorectal cancer in Stage II or III patients, and increases overall survival in pathological TNM Stage III."9.10Adjuvant therapy with protein-bound polysaccharide K and tegafur uracil in patients with stage II or III colorectal cancer: randomized, controlled trial. ( Ikeya, T; Kawashima, Y; Kawate, S; Kusaba, T; Morishita, Y; Nakajima, T; Nakamura, S; Ohwada, S; Roppongi, T; Takahashi, T; Yokomori, T, 2003)
"A trial was designed to examine the combination of UFT and mitomycin (Mutamycin) plus tamoxifen (Nolvadex) as postoperative adjuvant therapy in the treatment of patients with stage II, estrogen receptor (ER)-positive primary breast cancer."9.09UFT and mitomycin plus tamoxifen for stage II, ER-positive breast cancer. Hokkaido ACETBC Study Group. ( Asaishi, K; Hata, Y; Hirata, K; Kubo, Y; Mito, M; Ogita, M; Tanabe, T; Uchino, J, 1999)
"Low dose oral Folinic acid was used together with uracil with ftorafur (UFT) producing some response with low toxicity in advanced colorectal cancer."9.09Uracil with ftorafur and low dose oral folinic acid in advanced colorectal cancer. ( Arch-Yaemsuan, P; Boonnuch, W; Chakrapee-Sirisuk, S; Lert-Akayamanee, N; Lohsiriwat, D; Nimmanwudipong, T; Sinlarat, P; Srimuninnimit, V; Vathanophas, V, 2001)
"Combination therapy consisting of cyclophosphamide (CPA), adriamycin (ADR), UFT and endocrine therapy of oophorectomy or tamoxifen (TAM) was given female patients with advanced or recurrent breast cancer."9.07[Efficacy of combination therapy consisting of cyclophosphamide, adriamycin, UFT and oophorectomy/tamoxifen for advanced or recurrent breast cancer]. ( Abe, R; Kiman, K; Kimijima, I; Nihei, M; Sakonji, M; Satomi, T; Suzuki, S; Tanaka, T, 1994)
"Trifluridine/tipiracil (TFTD), with or without bevacizumab (Bev), and regorafenib are salvage chemotherapy options for metastatic colorectal cancer (mCRC)."8.12Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer. ( Boku, N; Hirano, H; Iwasa, S; Okita, N; Oshima, K; Shoji, H; Takashima, A, 2022)
"This study aimed to clarify the tolerability of a trifluridine/tipiracil combination tablet (TAS-102) in patients with advanced or recurrent colorectal cancer over 75 years of age."7.91Evaluation of Tolerability of Trifluridine/Tipiracil Combination Tablet in Patients With Advanced/Recurrent Colorectal Cancer. ( Kimura, M; Teramachi, H; Usami, E; Yoshimura, T, 2019)
"Elucidating the factors influencing severe neutropenia could aid in earlier management of neutropenia during oral trifluridine-tipiracil (TAS-102) chemotherapy in advanced and recurrent colorectal cancer (CRC)."7.88Risk factors contributing to the development of neutropenia in patients receiving oral trifluridine-tipiracil (TAS-102) chemotherapy for advanced/recurrent colorectal cancer. ( Ikeda, Y; Iwai, M; Kawachi, S; Kimura, M; Mitsuoka, M; Usami, E; Yasue, F; Yoshimura, T, 2018)
"To establish the sufficient therapy for elderly colorectal cancer patients, we retrospectively compared postoperative Tegafur/Uracil (UFT; Taiho Pharmaceutical Co."7.75Efficacy of postoperative UFT (Tegafur/Uracil) plus PSK therapies in elderly patients with resected colorectal cancer. ( Takashima, S; Yoshitani, S, 2009)
"We herein report the complete remission of multiple recurrent hepatocellular carcinomas (HCCs) by the oral administration of tegafur/uracil (UFT) alone."7.75Complete remission of multiple recurrent hepatocellular carcinomas by oral administration of enteric-coated tegafur/uracil in a patient with huge hepatocellular carcinoma extending to the inferior vena cava after hepatic resection: analysis of mRNA expres ( Asakawa, M; Fujii, H; Kono, H; Matsuda, M; Shiba, S, 2009)
"We evaluated combination therapy for advanced and recurrent breast cancer with cyclophosphamide (Cytoxan), doxorubicin (Adriamycin), UFT (uracil and tegafur), and tamoxifen (Nolvadex) (CAUT), designed as chemoendocrine therapy with a high antitumor effect and less severe adverse reactions."7.70Combination therapy for advanced breast cancer: cyclophosphamide, doxorubicin, UFT, and tamoxifen. ( Adachi, Y; Fukuda, M; Fukuma, E; Nakayama, Y; Nishikawa, T; Ogata, H; Ohta, T; Shimizu, K; Yamaguchi, S, 1999)
"Since June 1984, 23 cases of progressive or recurrent breast cancers were treated with combination chemotherapy of VAM-UFT consisting of vincristine, adriamycin, mitomycin C and UFT."7.67[Vincristine, adriamycin, mitomycin-C and UFT (VAM-UFT) therapy in progressive or recurrent breast cancer]. ( Hozumi, T; Imamura, Y; Irie, K; Katou, J; Matsushita, K; Okutani, T; Oya, M; Yasutake, K; Yoshimura, Y, 1989)
"The therapeutic efficacy of a regimen containing epirubicin (EPI) and vindesine (VDS) was evaluated in patients with breast cancer who were given a dose of 20 mg EPI and 3 mg VDS every 2 weeks."7.67[Combination chemotherapy using low-dose epirubicin and vindesine in patients with metastatic breast cancer]. ( Kawahara, T; Nakayama, H; Takatsuka, Y, 1988)
"Recurrence of hepatocellular carcinoma (HCC) after surgery is frequent, and is an important factor adversely influencing the long-term survival of patients."6.82Administration of adjuvant oral tegafur/uracil chemotherapy post hepatocellular carcinoma resection: A randomized controlled trial. ( Ishizuka, M; Iso, Y; Kato, M; Kubota, K; Nemoto, T; Shimoda, M; Tago, K, 2016)
"Frequent recurrence of hepatocellular carcinoma (HCC) after surgery remains a major clinical problem."6.72Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial. ( Hasegawa, K; Ijichi, M; Imamura, H; Kokudo, N; Makuuchi, M; Matsuyama, Y; Sano, K; Sugawara, Y; Takayama, T, 2006)
"Eniluracil, an effective inactivator of dihydropyrimidine dehydrogenase, allows for oral dosing of 5-fluorouracil (5-FU), which avoids the morbidity of continuous infusion 5-FU."6.71A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon. ( Anscher, MS; Cohen, DP; Czito, BG; Ertel, PJ; Honeycutt, W; Hong, TJ; Hurwitz, HI; Lee, CG; Lockhart, AC; Ludwig, KA; Mangum, SG; Mantyh, C; Morse, MA; Petros, WP; Seigler, HF; Spector, NL; Tyler, DS, 2004)
"Trifluridine/Tipiracil is a relatively new drug used in refractory mCRC."5.91Prognostic factors in refractory metastatic colorectal cancer patients treated with Trifluridine/Tipiracil. ( Bebyn, M; Koper, A; Koper, K; Śledzińska, P; Wileński, S, 2023)
"We included stage II colorectal cancer patients who underwent curative surgery and were followed up for at least 5 years after surgery at the National Taiwan University Hospital between January 2008 and December 2012."5.62Metronomic chemotherapy with tegafur-uracil following radical resection in stage II colorectal cancer. ( Chen, TC; Jeng, YM; Liang, JT, 2021)
"TAS-102 (trifluridine-tipiracil) has shown a significant overall survival benefit compared with placebo in patients with chemorefractory metastatic colorectal cancer."5.34TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial. ( Krogh, M; Möller, S; Petersen, LN; Pfeiffer, P; Poulsen, LØ; Qvortrup, C; Thomsen, KG; Winther, SB; Yilmaz, M; Zitnjak, D, 2020)
"Tissue samples from patients with pathologic ((p)) stage III colorectal cancer were tested for sensitivity to 5-fluorouracil (5-FU)."5.12An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer. ( Isogai, A; Kubota, S; Matsuoka, H; Nagaya, M; Tsukikawa, S; Watanabe, T, 2007)
"Adjuvant therapy using a combination of oral protein-bound polysaccharide K and tegafur/uracil is highly effective in preventing the recurrence of colorectal cancer in Stage II or III patients, and increases overall survival in pathological TNM Stage III."5.10Adjuvant therapy with protein-bound polysaccharide K and tegafur uracil in patients with stage II or III colorectal cancer: randomized, controlled trial. ( Ikeya, T; Kawashima, Y; Kawate, S; Kusaba, T; Morishita, Y; Nakajima, T; Nakamura, S; Ohwada, S; Roppongi, T; Takahashi, T; Yokomori, T, 2003)
"Low dose oral Folinic acid was used together with uracil with ftorafur (UFT) producing some response with low toxicity in advanced colorectal cancer."5.09Uracil with ftorafur and low dose oral folinic acid in advanced colorectal cancer. ( Arch-Yaemsuan, P; Boonnuch, W; Chakrapee-Sirisuk, S; Lert-Akayamanee, N; Lohsiriwat, D; Nimmanwudipong, T; Sinlarat, P; Srimuninnimit, V; Vathanophas, V, 2001)
"A trial was designed to examine the combination of UFT and mitomycin (Mutamycin) plus tamoxifen (Nolvadex) as postoperative adjuvant therapy in the treatment of patients with stage II, estrogen receptor (ER)-positive primary breast cancer."5.09UFT and mitomycin plus tamoxifen for stage II, ER-positive breast cancer. Hokkaido ACETBC Study Group. ( Asaishi, K; Hata, Y; Hirata, K; Kubo, Y; Mito, M; Ogita, M; Tanabe, T; Uchino, J, 1999)
"Patients with advanced measurable colorectal cancer who had failed previous therapy with intravenous bolus 5-fluorouracil (5-FU) were eligible."5.09Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer. ( Birkhofer, MJ; Ferreira, I; Meropol, NJ; Noel, D; Sonnichsen, DS, 1999)
"Combination therapy consisting of cyclophosphamide (CPA), adriamycin (ADR), UFT and endocrine therapy of oophorectomy or tamoxifen (TAM) was given female patients with advanced or recurrent breast cancer."5.07[Efficacy of combination therapy consisting of cyclophosphamide, adriamycin, UFT and oophorectomy/tamoxifen for advanced or recurrent breast cancer]. ( Abe, R; Kiman, K; Kimijima, I; Nihei, M; Sakonji, M; Satomi, T; Suzuki, S; Tanaka, T, 1994)
"We evaluated 63 patients with superficial bladder cancer (pTa, pTl) who were treated with instillation of bleomycin +/- bacillus Calmette-Guerin (BCG) and administration of uraciltfutraful (UFT) for prophylaxis of tumor recurrence after transurethral resection (TUR)."5.07[Prophylactic combination therapy after TUR of superficial bladder cancer]. ( Adachi, K; Ao, T; Endo, T; Kawakami, T; Koshiba, K; Mashimo, S; Uchida, T; Yokoyama, E, 1993)
"To evaluate the effect of UFT, a mixture of ftorafur and uracil in a ratio of 1:4, in preventing postoperative recurrence of bladder cancer, we performed a randomized controlled study with a non-medication group as control."5.06[Prophylactic effect of UFT on the recurrence of bladder cancer]. ( Ejiri, S; Hisazumi, H; Kanda, S; Katsumi, T; Kitagawa, K; Mikawa, I; Miyagi, T; Naito, K; Nakamura, T; Saka, A, 1990)
"Trifluridine/tipiracil (TFTD), with or without bevacizumab (Bev), and regorafenib are salvage chemotherapy options for metastatic colorectal cancer (mCRC)."4.12Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer. ( Boku, N; Hirano, H; Iwasa, S; Okita, N; Oshima, K; Shoji, H; Takashima, A, 2022)
"For patients with refractory metastatic colorectal cancer (mCRC) treatment with Trifluridine/Tipiracil, also known as TAS-102, improves overall survival."4.12Initial experience of TAS-102 chemotherapy in Australian patients with Chemo-refractory metastatic colorectal cancer. ( Ananda, S; Banks, S; Dunn, C; Gard, G; Gately, L; Gibbs, P; Jalali, A; Jennens, R; Khattak, A; Kosmider, S; Lee, B; Lee, M; Lim, L; Loft, M; McKendrick, J; Shapiro, JD; Tie, J; Wong, HL; Wong, R; Yeung, JM, 2022)
"Trifluridine/tipiracil (TAS-102) is an important chemotherapeutic agent recommended by the Japanese guidelines as third- or fourth-line treatment for colorectal cancer."4.02[Two Cases of Metastatic Colorectal Cancer Treated with TAS-102 plus Bevacizumab]. ( Amagasa, H; Ami, K; Ando, M; Fukuda, A; Gan, S; Ganno, H; Iida, S; Imai, K; Kajiyama, D; Kawaguchi, M; Maeda, F; Motoyama, K; Okano, Y; Tokitou, F; Yamada, A, 2021)
"This study aimed to clarify the tolerability of a trifluridine/tipiracil combination tablet (TAS-102) in patients with advanced or recurrent colorectal cancer over 75 years of age."3.91Evaluation of Tolerability of Trifluridine/Tipiracil Combination Tablet in Patients With Advanced/Recurrent Colorectal Cancer. ( Kimura, M; Teramachi, H; Usami, E; Yoshimura, T, 2019)
"Elucidating the factors influencing severe neutropenia could aid in earlier management of neutropenia during oral trifluridine-tipiracil (TAS-102) chemotherapy in advanced and recurrent colorectal cancer (CRC)."3.88Risk factors contributing to the development of neutropenia in patients receiving oral trifluridine-tipiracil (TAS-102) chemotherapy for advanced/recurrent colorectal cancer. ( Ikeda, Y; Iwai, M; Kawachi, S; Kimura, M; Mitsuoka, M; Usami, E; Yasue, F; Yoshimura, T, 2018)
"The effect of oral trifluridine-tipiracil (TAS-102)-induced neutropenia on survival of patients with advanced/recurrent colorectal cancer was investigated."3.85Severe neutropenia: a prognosticator in patients with advanced/recurrent colorectal cancer ( Iwai, M; Kimura, M; Teramachi, H; Usami, E; Yoshimura, T, 2017)
"To establish the sufficient therapy for elderly colorectal cancer patients, we retrospectively compared postoperative Tegafur/Uracil (UFT; Taiho Pharmaceutical Co."3.75Efficacy of postoperative UFT (Tegafur/Uracil) plus PSK therapies in elderly patients with resected colorectal cancer. ( Takashima, S; Yoshitani, S, 2009)
"We herein report the complete remission of multiple recurrent hepatocellular carcinomas (HCCs) by the oral administration of tegafur/uracil (UFT) alone."3.75Complete remission of multiple recurrent hepatocellular carcinomas by oral administration of enteric-coated tegafur/uracil in a patient with huge hepatocellular carcinoma extending to the inferior vena cava after hepatic resection: analysis of mRNA expres ( Asakawa, M; Fujii, H; Kono, H; Matsuda, M; Shiba, S, 2009)
"To evaluate ambulatory patient cancer chemotherapy, the clinical response, toxicities and survival time were analysed among 19 patients with non-curative or recurrent colorectal cancer who were treated by Uracil/Tegafur (UFT) plus oral Leucovorin (UZEL) for the past 2 years."3.73[Clinical study of ambulatory patient cancer chemotherapy for advanced colorectal cancer]. ( Fujiwara, H; Hamabe, Y; Ishida, T; Kaji, M; Mukai, H; Mukubou, H; Onishi, N; Sato, S; Toyokawa, A; Tsujimura, T; Tsukamoto, T; Wakahara, T; Wakita, K; Watanabe, A, 2005)
"We evaluated combination therapy for advanced and recurrent breast cancer with cyclophosphamide (Cytoxan), doxorubicin (Adriamycin), UFT (uracil and tegafur), and tamoxifen (Nolvadex) (CAUT), designed as chemoendocrine therapy with a high antitumor effect and less severe adverse reactions."3.70Combination therapy for advanced breast cancer: cyclophosphamide, doxorubicin, UFT, and tamoxifen. ( Adachi, Y; Fukuda, M; Fukuma, E; Nakayama, Y; Nishikawa, T; Ogata, H; Ohta, T; Shimizu, K; Yamaguchi, S, 1999)
"Since June 1984, 23 cases of progressive or recurrent breast cancers were treated with combination chemotherapy of VAM-UFT consisting of vincristine, adriamycin, mitomycin C and UFT."3.67[Vincristine, adriamycin, mitomycin-C and UFT (VAM-UFT) therapy in progressive or recurrent breast cancer]. ( Hozumi, T; Imamura, Y; Irie, K; Katou, J; Matsushita, K; Okutani, T; Oya, M; Yasutake, K; Yoshimura, Y, 1989)
"The therapeutic efficacy of a regimen containing epirubicin (EPI) and vindesine (VDS) was evaluated in patients with breast cancer who were given a dose of 20 mg EPI and 3 mg VDS every 2 weeks."3.67[Combination chemotherapy using low-dose epirubicin and vindesine in patients with metastatic breast cancer]. ( Kawahara, T; Nakayama, H; Takatsuka, Y, 1988)
"Irinotecan was supplied at doses of 40, 50, 60, and 70 mg/m(2) by using a standard 3+3 design."2.82Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/II Clinical Study. ( Chang, PM; Chen, SC; Yang, MH, 2016)
"Patients aged 20-80 with stage II/III rectal cancer undergoing curative surgery without preoperative therapy were randomly assigned to receive UFT (500-600 mg/day on days 1-5, followed by 2 days rest) or S-1 (80-120 mg/day on days 1-28, followed by 14 days rest) for 1 year."2.82A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC). ( Baba, H; Emi, Y; Hamada, C; Ikejiri, K; Kakeji, Y; Kotake, M; Maeda, K; Maehara, Y; Matsuda, C; Matsuda, H; Munemoto, Y; Murata, A; Oki, E; Saji, S; Sasaki, K; Suenaga, T; Yoshida, K, 2016)
"Recurrence of hepatocellular carcinoma (HCC) after surgery is frequent, and is an important factor adversely influencing the long-term survival of patients."2.82Administration of adjuvant oral tegafur/uracil chemotherapy post hepatocellular carcinoma resection: A randomized controlled trial. ( Ishizuka, M; Iso, Y; Kato, M; Kubota, K; Nemoto, T; Shimoda, M; Tago, K, 2016)
"Etoposide 50 mg/m(2), UFT 250 mg/m(2) and leucovorin 90 mg (fixed dose) were dosed in 3 gifts approximately 8h apart for 14 days followed by 1 week rest every 3 weeks until progressive disease (PD)."2.74Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: a non-randomized phase II study. ( Aerts, JG; Gras, J; Hoogsteden, H; Pouw, E; Pronk, T; Salomé, J; Schmitz, PI; Surmont, V; Tan, KY; van Klaveren, RJ; Vernhout, R, 2009)
"Twenty-two patients with metastatic colorectal cancer were enrolled in the phase I trial and 35 patients (including eight patients treated at level 4 during phase I) were evaluated in the phase II trial."2.73Phase I/II study of CPT-11 plus UFT in patients with advanced/recurrent colorectal cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG): Protocol 0102. ( Fukunaga, M; Furukawa, H; Gotoh, M; Ishida, H; Ishihara, R; Narahara, H; Okamura, S; Takiuchi, H; Tomita, N; Uedo, N, 2007)
"Frequent recurrence of hepatocellular carcinoma (HCC) after surgery remains a major clinical problem."2.72Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial. ( Hasegawa, K; Ijichi, M; Imamura, H; Kokudo, N; Makuuchi, M; Matsuyama, Y; Sano, K; Sugawara, Y; Takayama, T, 2006)
") gemcitabine (GEM) at low dose plus oral chemotherapy with uracil-tegafur (UFT) and cyclophosphamide (CPA) in combination with radiotherapy (RT) against recurrent and advanced pancreatic cancers."2.71Phase II study on low dose gemcitabine plus oral chemotherapy with uracil-tegafur and cyclophosphamide in combination with radiotherapy against recurrent and advanced pancreatic cancer. ( Endo, S; Hashimoto, K; Higami, T; Itakura, M; Koike, M; Maruyama, R; Nio, Y; Tsuji, M; Yamaguchi, K; Yano, S, 2005)
" Administration of more than 2 courses was attempted for each patient, with the same dosage levels at all 3 scheduled steps."2.71[Phase I study of gemcitabine (GEM) and UFT combination chemotherapy for unresectable/recurrent pancreatic cancer]. ( Dono, K; Maruhashi, S; Miyamoto, A; Monden, M; Nagano, H; Nakamori, S; Sakon, M; Takahashi, Y; Tujie, M; Umeshita, K, 2004)
"Eniluracil, an effective inactivator of dihydropyrimidine dehydrogenase, allows for oral dosing of 5-fluorouracil (5-FU), which avoids the morbidity of continuous infusion 5-FU."2.71A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon. ( Anscher, MS; Cohen, DP; Czito, BG; Ertel, PJ; Honeycutt, W; Hong, TJ; Hurwitz, HI; Lee, CG; Lockhart, AC; Ludwig, KA; Mangum, SG; Mantyh, C; Morse, MA; Petros, WP; Seigler, HF; Spector, NL; Tyler, DS, 2004)
" dosing without requiring any i."2.70Phase I study of oral uracil and Tegafur plus leucovorin and pelvic radiation in patients with recurrent rectal cancer. ( Dunst, J; Engenhart-Cabillic, R; Hess, CF; Hoffmann, W; Reese, T; Schiebe, ME; Schmidberger, H; Wenz, F, 2002)
"5-Fluorouracil (5-FU) is an effective enhancer of radiation therapy (RT) in head and neck cancers."2.69Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer. ( Brockstein, B; Dolan, ME; Haraf, DJ; Humerickhouse, RA; Kies, M; Ratain, MJ; Stenson, K; Sulzen, L; Vokes, EE, 1999)
"For locally unresectable recurrent squamous cell carcinoma of the head and neck, we investigated two salvage chemotherapy regimens as second-line chemotherapy."2.69Prognosis after salvage chemotherapy for locally unresectable recurrent squamous cell carcinoma of the head and neck. ( Kawaida, M; Kitahara, S; Kohno, N; Ohmuma, T, 1999)
"For 27 outpatients with advanced cancer of the digestive system including 15 cases of esophageal cancer, 4 cases of gastric cancer, 3 cases of colon cancer, 4 cases of pancreatic cancer and 1 case of gall bladder cancer, 4 to 6 week home adjuvant chemotherapy was performed."2.68[Combined chemotherapy with 5-FU and low dose CDDP for advanced or recurrent cancer of the digestive system and home anti-cancer chemotherapy]. ( Araki, H; Hiramatsu, Y; Kamiyama, Y; Kojima, Y; Nakagawa, A; Nakagawa, M; Ogura, T; Shirasaka, T, 1995)
"According to the Japan Mammary Cancer Society's criteria of response, more than partial response was observed in 11 out of 32 cases (34."2.65[Clinical trial of UFT against disseminated breast cancer]. ( Harauchi, D; Itoh, S; Konishi, Y; Shinoto, M, 1984)
"The preoperative diagnosis was giant hepatocellular carcinoma (HCC) of the right hepatic anterior region, and extended anterior segmentectomy of the liver was performed."2.42[Complete disappearance with oral UFT administration of recurrent hepatocellular carcinoma of the remnant liver and multiple lung metastasis after hepatic resection]. ( Hanazaki, K; Kawasaki, S; Kobayashi, A; Matsushita, A; Misawa, R; Miwa, S; Miyagawa, S; Nakagawa, K; Nakata, T; Noike, T; Nomura, K, 2003)
"The common clinical presentations of head and neck cancer include early (stage I or II) disease, locally or regionally advanced (stage III or IV, M0) disease, and recurrent or metastatic disease (< 5% of patients)."2.40Oral 5-FU alternatives for the treatment of head and neck cancer. ( Brockstein, BE; Haraf, DJ; Humerickhouse, R; Vokes, EE, 1998)
"Trifluridine/Tipiracil is a relatively new drug used in refractory mCRC."1.91Prognostic factors in refractory metastatic colorectal cancer patients treated with Trifluridine/Tipiracil. ( Bebyn, M; Koper, A; Koper, K; Śledzińska, P; Wileński, S, 2023)
"We included stage II colorectal cancer patients who underwent curative surgery and were followed up for at least 5 years after surgery at the National Taiwan University Hospital between January 2008 and December 2012."1.62Metronomic chemotherapy with tegafur-uracil following radical resection in stage II colorectal cancer. ( Chen, TC; Jeng, YM; Liang, JT, 2021)
"A total of 118 rectal cancer patients receiving preoperative CRT were enrolled."1.51Identification of Predictors of Recurrence in Patients with Lower Rectal Cancer Undergoing Neoadjuvant Chemotherapy: A Direct Comparison of Short-Course and Long-Course Chemoradiotherapy. ( Araki, T; Fujikawa, H; Hiro, J; Ide, S; Kusunoki, M; Ohi, M; Okugawa, Y; Saigusa, S; Toiyama, Y; Yamamoto, A; Yasuda, H; Yoshiyama, S, 2019)
" Details of serious adverse events (SAEs) were recorded."1.46Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort. ( Albillos, A; Ampuero, J; Arenas, J; Bañares, R; Calleja, JL; Crespo, J; Diago, M; Fernandez, I; García-Eliz, M; García-Samaniego, J; Gea, F; Jorquera, F; Lens, S; Llaneras, J; Llerena, S; Mariño, Z; Morillas, RM; Muñoz, R; Navascues, CA; Pascasio, JM; Perelló, C; Rincón, D; Rodriguez, CF; Ruiz-Antorán, B; Sacristán, B; Serra, MA; Simon, MA; Torras, X; Turnes, J, 2017)
"The tumor was diagnosed as breast carcinoma using a core needle biopsy."1.43[A Case of Primary Acinic Cell Carcinoma(ACC)of the Breast]. ( Iga, N; Ikeda, H; Ishizaki, M; Kawai, H; Nishi, H; Sugimoto, R; Waki, N; Yamashita, K; Yoshida, R, 2016)
" Moreover, we recommend that, for patients with repeated treatment postponement due to neutropenia, the dosage should be fixed based on therapeutic efficacy and prognosis."1.43Safety of an oral anticancer agent (trifluridine/tipiracil combination tablet) in patients with advanced and recurrent colorectal cancer. ( Asano, H; Go, M; Ito, D; Iwai, M; Kimura, M; Teramachi, H; Usami, E; Yoshimura, T, 2016)
"Biliary papillomatosis is rare, and its pathogenic mechanisms are not yet clear."1.42Volume-reserving Surgery after Photodynamic Therapy for Biliary Papillomatosis: A Case Report. ( Cheong, CO; Kim, HK; Kim, KS; Lim, JH; Park, JS; Park, SW, 2015)
"We recruited 93 rectal cancer patients who underwent neoadjuvant CRT and radical resection."1.40CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer. ( Hase, K; Hashiguchi, Y; Ishiguro, M; Kajiwara, Y; Kobayashi, H; Sekizawa, A; Shikina, A; Shinto, E; Ueno, H; Yamamoto, J, 2014)
"We report a case of local recurrent colorectal cancer that has been treated successfully with low-dose oral chemotherapeutic agent."1.36[A case of local relapsed rectal cancer responding to low-dose S-1]. ( Fujita, S; Ikeda, N; Kanamura, T; Kojima, Y; Nakagawa, K; Ueno, M, 2010)
"Sigmoidectomy was performed for sigmoid colon cancer in January 2002."1.36[A case of recurrent sigmoid colon cancer with adrenal and para-aortic lymph node metastasis successfully treated by operation and chemotherapy]. ( Doki, Y; Hirose, H; Ikeda, M; Kim, HM; Miyoshi, N; Mizushima, T; Mori, M; Okano, M; Sekimoto, M; Takemasa, I; Yamamoto, H; Yamashita, S, 2010)
" The regimen of pre-op CCRT was a radiation dosage of 45  Gy in 20 fractions and oral tegafur-uracil (UFUR) and leucovorin."1.36The impact of preoperative chemoradiotherapy on advanced low rectal cancer. ( Chang, SC; Chen, WS; Jiang, JK; Kao, PS; Lee, RC; Liang, WY; Lin, JK; Lin, TC; Wang, HS; Wang, LW; Yang, SH, 2010)
"These results suggest that the anticancer effect of S-1 can be predicted by performing UrBT 3 h after the initial oral S-1 administration."1.36Can the 2-(13)C-uracil breath test be used to predict the effect of the antitumor drug S-1? ( Asai, S; Ishii, Y; Suzuki, S; Takahashi, Y; Takayama, T, 2010)
"We report two cases of squamous cell carcinoma of upper urinary tract with hypercalcemia."1.35[Two cases of squamous cell carcinoma of upper urinary tract with hypercalcemia]. ( Kobayashi, Y; Matsuzaki, A; Terauchi, F; Washino, S, 2008)
"For patients with T3N0M0 colon cancer without known risk factors, the necessity of chemotherapy has no definite consensus."1.35The necessity of chemotherapy in T3N0M0 colon cancer without risk factors. ( Cho, YB; Chun, HK; Kim, HC; Lee, WY; Yun, HR; Yun, SH, 2009)
"Advanced ovarian cancer is a chemosensitive tumor and most patients initially respond to platinum-based combination chemotherapy with response rates of about 70%, including a high proportion of complete responses."1.35Complete remission of platinium refractory ovarian cancer with second line tegafur with uracil monotherapy: a case report. ( Aslan, Y; Buyukberber, S; Camci, C; Kalender, ME; Sevinc, A, 2009)
"Primary liver cancer with lymph node metastasis was recognized as poor prognosis."1.35[A case report of combined hepatocellular-cholangiocarcinoma whose lymph node recurrence effectively treated with UFT]. ( Akagi, K; Dono, K; Fujita, J; Hata, T; Hayashi, S; Ikeda, K; Kagawa, Y; Kawanishi, K; Kitada, M; Munakata, K; Shimano, T; Shimizu, J; Takamoto, K; Watanabe, N; Yasumoto, T; Zenitani, M, 2009)
"Advanced or recurrent pancreatic cancer can sometimes cause obstruction or stenosis of the portal vein (PV), resulting in various symptoms of portal hypertension (PH), such as ascites, pancytopenia, hemorrhagic tendencies and liver dysfunction."1.35Placement of an expandable metallic stent improves the efficacy of chemoradiotherapy for pancreatic cancer with malignant portal vein stenosis or obstruction. ( Endo, S; Hashimoto, K; Iguchi, C; Itakura, M; Koike, M; Nio, Y; Nishi, T; Omori, H; Sato, Y; Takamura, M; Takeda, H, 2009)
"Thirty-three patients with rectal cancer underwent preoperative CRT."1.35Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. ( Ioue, Y; Kusunoki, M; Miki, C; Okugawa, Y; Saigusa, S; Tanaka, K; Toiyama, Y; Yokoe, T, 2009)
" A dosage of 335 mg/m2/day of UFT was given perorally on daily schedule."1.34Metronomic chemotherapy using weekly low-dosage CPT-11 and UFT as postoperative adjuvant therapy in colorectal cancer at high risk to recurrence. ( Akagi, Y; Fukushima, T; Ishibashi, N; Mori, S; Murakami, H; Ogata, Y; Shirouzu, K; Ushijima, M, 2007)
"The data on 307 patients with colorectal cancer at stage II or III, who underwent potentially curative resection with lymphadenectomy, were reviewed."1.33The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer. ( Ikeda, S; Ishibashi, N; Matono, K; Mizobe, T; Ogata, Y; Ogo, S; Ohkita, A; Ozasa, H; Sasatomi, T; Shirouzu, K, 2006)
"The patient diagnosed as recurrent pancreatic cancer was treated with UFT combined gemcitabine (GEM) chemotherapy."1.33[A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease]. ( Kagaya, T; Kaneko, S; Kato, Y; Sunagozaka, H; Yamashita, T, 2006)
"68 patients with clinical T3-4NxM0 rectal cancer were treated with surgery alone [Group II]."1.32Preoperative radio/chemo-radiotherapy in combination with intraoperative radiotherapy for T3-4Nx rectal cancer. ( Fukasawa, M; Ishikawa, K; Makuuchi, H; Murayama, C; Ohizumi, Y; Sadahiro, S; Saguchi, T; Suzuki, T; Yasuda, S, 2004)
"The mean PyNPase activity of primary breast cancer, assayed by ELISA method, was 140."1.30[Prognostic effect of PyNPase (pyrimidine nucleoside phosphorylase) activity in breast cancer]. ( Baba, K; Fukuda, M; Higuchi, A; Masuyama, S; Matsuda, M; Matsumoto, H; Matsuoka, Y; Miyayama, H; Nagao, K; Nishimura, R; Uchino, S; Yamashita, H, 1998)
"These two cases showed no recurrent liver cancers."1.28[Results of prophylactic intra-arterial infusion chemotherapy after hepatic resection in colorectal metastases]. ( Houjo, K; Kawano, N; Moriya, Y; Sugihara, K, 1990)
"A Case of local recurrent breast cancer in a 45-year-old female with complete response to Combination of chemotherapy and topical administration of Adriamycin is reported."1.28[A case of local recurrent breast cancer with complete response to combination of systemic chemotherapy and topical use of adriamycin ointment]. ( Deguchi, S; Hokama, A; Kurihara, K; Muto, Y; Nomura, K; Toda, T, 1990)
"This is a rare case of renal cell carcinoma with local recurrence and lung metastasis successfully treated with UFT."1.28[A case of renal cell carcinoma with lung metastasis and local recurrence effectively treated with nephrectomy and UFT]. ( Matsuda, M; Taguchi, H; Takaoka, K, 1992)
"A case of local recurrence of rectal cancer was successfully treated by UFT combined with two-route CDDP chemotherapy under the AT-II induced hypertension."1.28[A case of local recurrence of rectal cancer successfully treated by UFT combined with two-route CDDP chemotherapy under the AT-II induced hypertension]. ( Ishizawa, T; Iwashige, H; Maenohara, S; Mure, H; Shimazu, H; Takao, S; Yamada, K, 1991)
"He was diagnosed as having right renal cell carcinoma which had metastasized to the lung."1.28[A case of recurrence of a metastatic brain tumor which disappeared due to chemotherapy only]. ( Kayama, T; Ogawa, A; Sakurai, Y; Sato, K; Wada, T, 1990)
"A 56-year-old woman with recurrent gastric cancer treated with PMU therapy, combined CDDP 75 mg/m2 i."1.27[PMU therapy of recurrent gastric cancer. A case report]. ( Matsuki, N; Miyata, R; Miyazaka, I; Noto, H; Ogino, S; Ohyama, S; Sakuma, H; Sawa, T; Yagi, M; Yonemura, Y, 1986)
"In 8 cases of advanced and/or relapsed gastric cancer (7 cases advanced, 1 case relapsed), we undertook combination chemotherapy with systemic administration of cisplatin and celiac arterial infusion of carboquone intermittently under continuous administration of OK-432 i."1.27[Clinical study of combination chemotherapy using carboquone, cisplatin, UFT and OK-432 in 7 cases of advanced gastric cancers and a relapsed gastric cancer]. ( Horiuchi, M; Nakarai, I; Nasu, K; Shinoda, A, 1988)

Research

Studies (145)

TimeframeStudies, this research(%)All Research%
pre-199011 (7.59)18.7374
1990's40 (27.59)18.2507
2000's48 (33.10)29.6817
2010's35 (24.14)24.3611
2020's11 (7.59)2.80

Authors

AuthorsStudies
Jalali, A1
Gard, G1
Banks, S1
Dunn, C1
Wong, HL1
Wong, R1
Lee, M1
Gately, L1
Loft, M1
Shapiro, JD1
Kosmider, S1
Tie, J1
Ananda, S1
Yeung, JM1
Jennens, R1
Lee, B1
McKendrick, J1
Lim, L1
Khattak, A1
Gibbs, P1
Sadahiro, S3
Sakamoto, K2
Tsuchiya, T2
Takahashi, T4
Ohge, H2
Sato, T2
Kondo, K2
Ogata, Y4
Baba, H4
Itabashi, M2
Ikeda, M4
Hamada, M2
Maeda, K3
Masuko, H2
Takahashi, K5
Sakamoto, J1
Kusano, M1
Hyodo, I1
Taguri, M2
Morita, S2
Okamoto, K2
Kaku, R1
Oshio, Y1
Hanaoka, J1
Oshima, K1
Hirano, H1
Shoji, H1
Iwasa, S1
Okita, N1
Takashima, A1
Boku, N1
Miyashita, S1
Shimizu, T2
Ishizuka, M2
Niki, M1
Nishi, Y1
Shibuya, N1
Hachiya, H1
Matsumoto, T1
Sakuraoka, Y1
Shiraki, T1
Mori, S2
Iso, Y2
Irisawa, A1
Aoki, T2
Koper, A1
Wileński, S1
Śledzińska, P1
Bebyn, M1
Koper, K1
Liang, SK1
Wu, CW1
Chang, CI1
Keng, LT1
Lee, MR1
Wang, JY1
Ko, JC1
Liao, WY1
Chen, KY1
Ho, CC1
Shih, JY1
Yu, CJ1
Pfeiffer, P3
Yilmaz, M1
Möller, S1
Zitnjak, D1
Krogh, M1
Petersen, LN1
Poulsen, LØ1
Winther, SB1
Thomsen, KG1
Qvortrup, C1
Chen, TC1
Jeng, YM1
Liang, JT1
Hamada, S2
Komatsu, S1
Shibata, R1
Konishi, T1
Matsubara, D1
Soga, K1
Shimomura, K1
Ikeda, J1
Taniguchi, F1
Shioaki, Y1
Maeda, F1
Gan, S1
Yamada, A1
Kajiyama, D1
Tokitou, F1
Kawaguchi, M1
Amagasa, H1
Motoyama, K1
Ganno, H1
Imai, K1
Ami, K1
Iida, S1
Fukuda, A1
Ando, M1
Okano, Y1
Kimura, M4
Usami, E4
Iwai, M3
Teramachi, H3
Yoshimura, T4
Arnold, D1
Prager, GW1
Quintela, A1
Stein, A1
Moreno Vera, S1
Mounedji, N1
Taieb, J1
Yasue, F1
Kawachi, S1
Mitsuoka, M1
Ikeda, Y1
Matsuda, C3
Ishiguro, M3
Teramukai, S2
Kajiwara, Y2
Fujii, S2
Kinugasa, Y1
Nakamoto, Y2
Kotake, M3
Sakamoto, Y2
Kurachi, K2
Maeda, A1
Komori, K1
Tomita, N3
Shimada, Y1
Kotake, K1
Watanabe, M1
Mochizuki, H1
Nakagawa, Y1
Sugihara, K3
Yamamoto, A1
Toiyama, Y2
Okugawa, Y2
Saigusa, S2
Ide, S1
Fujikawa, H1
Hiro, J1
Yasuda, H1
Yoshiyama, S1
Ohi, M1
Araki, T1
Kusunoki, M2
Kashiwabara, K1
Semba, H1
Tsumura, S1
Hayashi, M1
Nakamura, K1
Terai, S1
Sakai, S1
Kinoshita, J2
Hayashi, H1
Oyama, K1
Miyashita, T1
Inokuchi, M1
Tajima, H1
Takamura, H1
Ninomiya, I1
Fushida, S1
Ohta, T2
Ueno, H2
Nakatani, E1
Ishikawa, T1
Uetake, H1
Egawa, T1
Yasumasa, K1
Murata, K1
Ikawa, O1
Shinji, S1
Murotani, K1
Matsui, S1
Preda, CM1
Baicus, C1
Sandra, I1
Oproiu, A1
Manuc, T1
Constantinescu, I1
Gavrila, D1
Diculescu, M1
Dumitru, R1
Vasilescu, C1
Tieranu, C1
Istratescu, D1
Voiosu, T1
Manuc, M1
Shinto, E1
Hase, K1
Hashiguchi, Y1
Sekizawa, A1
Shikina, A1
Kobayashi, H1
Yamamoto, J1
Draoui, N1
Schicke, O1
Seront, E1
Bouzin, C1
Sonveaux, P1
Riant, O1
Feron, O1
Maeda, T1
Hashimoto, K3
Ishida, T2
Yamashita, Y1
Saeki, H1
Kawanaka, H1
Uchiyama, H1
Ikeda, T2
Tsujitani, S1
Maehara, Y4
Twu, CW1
Wang, WY1
Chen, CC1
Liang, KL1
Jiang, RS1
Wu, CT1
Shih, YT1
Lin, PJ1
Liu, YC1
Lin, JC1
Tashiro, J1
Yamaguchi, S3
Ishii, T1
Suzuki, A1
Kondo, H1
Morita, Y1
Hara, K1
Koyama, I1
Hishida, T1
Tsuboi, M1
Shukuya, T1
Takamochi, K1
Sakurai, H1
Yoh, K1
Ohashi, Y1
Kunitoh, H1
Sasaki, K3
Nishimura, G1
Kodaira, S2
Kubota, K1
Nemoto, T1
Shimoda, M1
Kato, M1
Tago, K1
Cheong, CO1
Lim, JH1
Park, JS1
Park, SW1
Kim, HK1
Kim, KS1
Oki, E1
Murata, A1
Yoshida, K3
Ikejiri, K1
Munemoto, Y1
Suenaga, T1
Matsuda, H1
Emi, Y1
Kakeji, Y2
Hamada, C1
Saji, S1
Goldberg, R1
Chen, SC1
Chang, PM1
Yang, MH1
Go, M1
Ito, D1
Asano, H1
Kawai, H1
Sugimoto, R1
Iga, N1
Ikeda, H1
Yoshida, R1
Waki, N1
Ishizaki, M1
Nishi, H1
Yamashita, K1
Calleja, JL1
Crespo, J1
Rincón, D1
Ruiz-Antorán, B1
Fernandez, I1
Perelló, C1
Gea, F1
Lens, S1
García-Samaniego, J1
Sacristán, B1
García-Eliz, M1
Llerena, S1
Pascasio, JM1
Turnes, J1
Torras, X1
Morillas, RM1
Llaneras, J1
Serra, MA1
Diago, M1
Rodriguez, CF1
Ampuero, J1
Jorquera, F1
Simon, MA1
Arenas, J1
Navascues, CA1
Bañares, R1
Muñoz, R1
Albillos, A1
Mariño, Z1
Rivera, F1
Eugenia Vega-Villegas, M1
López, C1
Francisca López-Brea, M1
Rubio, A1
Del Valle, A1
García-Reija, F1
García-Montesinos, B1
Rodríguez-Iglesias, J1
Hinojo, C1
Márquez, R1
Angel Alonso-Bermejo, M1
Salcedo, M1
Blanco, Y1
Vega, N1
López-Tarruella, S1
Sanz-Ortiz, J1
Washino, S1
Terauchi, F1
Matsuzaki, A1
Kobayashi, Y1
Takagi, S1
Misawa, R2
Iinuma, N1
Uchikawa, Y1
Kameyama, H1
Takii, Y1
Nomura, T1
Nakagawa, S1
Yabusaki, H1
Tsuchiya, Y1
Nashimoto, A1
Tanaka, O1
Yoshitani, S1
Takashima, S1
Surmont, V1
Aerts, JG1
Pouw, E1
Tan, KY1
Vernhout, R1
Gras, J1
Salomé, J1
Pronk, T1
Schmitz, PI1
Hoogsteden, H1
van Klaveren, RJ1
Obuchi, T1
Sasaki, A1
Shimooki, O1
Minakawa, Y1
Abe, T1
Nitta, H1
Otsuka, K1
Koeda, K1
Ikeda, K2
Wakabayashi, G1
Huh, JW1
Kim, HR1
Matsuda, M3
Shiba, S1
Asakawa, M1
Kono, H1
Fujii, H1
Tanaka, K1
Yokoe, T1
Ioue, Y1
Miki, C1
Nio, Y3
Iguchi, C2
Itakura, M2
Nishi, T1
Takeda, H1
Takamura, M1
Omori, H1
Sato, Y3
Koike, M2
Endo, S2
Yun, HR1
Kim, HC1
Lee, WY1
Cho, YB1
Yun, SH1
Chun, HK1
Ishii, Y1
Suzuki, S2
Takahashi, Y2
Takayama, T2
Asai, S1
Hazra, A1
Selhub, J1
Chao, WH1
Ueland, PM1
Hunter, DJ1
Baron, JA1
Shimizu, J1
Hayashi, S1
Dono, K3
Yasumoto, T1
Zenitani, M1
Munakata, K1
Watanabe, N1
Takamoto, K1
Kagawa, Y2
Hata, T1
Kawanishi, K1
Fujita, J1
Akagi, K1
Kitada, M1
Shimano, T1
Kao, PS1
Chang, SC1
Wang, LW1
Lee, RC1
Liang, WY1
Lin, TC1
Chen, WS1
Jiang, JK1
Yang, SH1
Wang, HS1
Lin, JK1
Kim, HM2
Okano, M1
Miyoshi, N1
Hirose, H2
Yamashita, S2
Takemasa, I2
Mizushima, T3
Yamamoto, H3
Sekimoto, M2
Doki, Y2
Mori, M2
Nakagawa, K2
Ueno, M1
Kanamura, T1
Kojima, Y2
Fujita, S1
Ikeda, N1
Goto, H1
Ikenaga, M1
Yasui, M1
Miyazaki, M2
Mishima, H1
Tsujie, M2
Miyamoto, A3
Hirao, M1
Fujitani, K1
Nakamori, S3
Tsujinaka, T1
Katsuta, E1
Ohkubo, T1
Someno, Y1
Saguchi, M1
Aoyagi, H1
Takahata, T1
Hasegawa, K2
Kaneko, J1
Maejima, S1
Vestermark, LW1
Jensen, HA1
Matsushita, N1
Aruga, A1
Inoue, Y1
Kotera, Y1
Takeda, K1
Yamamoto, M1
Sugiyama, Y1
Kato, T2
Nakazato, H1
Ito, K1
Mizuno, I1
Kanemitsu, T1
Matsumoto, K1
Yamaguchi, A1
Nakai, K1
Inada, K1
Tatematsu, M1
Schiebe, ME1
Reese, T1
Wenz, F1
Schmidberger, H1
Engenhart-Cabillic, R1
Dunst, J1
Hess, CF1
Hoffmann, W2
Ishida, H2
Takeuchi, I1
Ohsawa, T1
Nakada, H1
Ishizuka, N1
Yokoyama, M2
Inokuma, S1
Suzuki, T2
Yamada, H1
Odaka, A1
Hoshino, T1
Murata, N1
Hashimoto, D1
Matsumoto, Y1
Miura, T1
Shimizu, C1
Watanabe, T2
Ohwada, S2
Kawate, S1
Ikeya, T1
Yokomori, T1
Kusaba, T1
Roppongi, T1
Nakamura, S1
Kawashima, Y2
Nakajima, T1
Morishita, Y1
Matsushita, A1
Hanazaki, K1
Noike, T1
Nakata, T1
Nomura, K2
Kobayashi, A1
Miwa, S1
Miyagawa, S1
Kawasaki, S1
Mori, T2
Yamaguchi, T1
Matsumoto, H2
Miyamoto, H1
Arai, K1
Iwasaki, Y1
Katayanagi, S1
Doi, T1
Ohtsu, A1
Nagasaki, E1
Furuta, N2
Shinozaki, E1
Tokutome, N1
Mishima, Y1
Chin, K1
Terui, Y1
Mizunuma, N1
Takahashi, S1
Itoh, Y1
Usui, N1
Hatake, K1
Kikkawa, N1
Iijima, S1
Handa, R1
Naoi, Y1
Oshima, S1
Kurokawa, E1
Tujie, M1
Maruhashi, S1
Nagano, H2
Umeshita, K2
Sakon, M2
Monden, M2
Czito, BG1
Hong, TJ1
Cohen, DP1
Tyler, DS1
Lee, CG1
Anscher, MS1
Ludwig, KA1
Seigler, HF1
Mantyh, C1
Morse, MA1
Lockhart, AC1
Petros, WP1
Honeycutt, W1
Spector, NL1
Ertel, PJ1
Mangum, SG1
Hurwitz, HI1
Watanabe, O1
Imamura, H2
Okabe, T1
Ogawa, K1
Haga, S1
Ishikawa, K2
Fukasawa, M1
Saguchi, T1
Yasuda, S1
Makuuchi, H1
Murayama, C1
Ohizumi, Y1
Altundag, O1
Altundag, K1
Gunduz, M1
Oya, R1
Ikemura, K1
Nakamura, M1
Kondo, M1
Yamamoto, T1
Ota, H1
Wada, H1
Damdinsuren, B1
Yang, Y1
Marubashi, S1
Yano, S2
Yamaguchi, K1
Tsuji, M1
Higami, T1
Maruyama, R1
Matono, K1
Sasatomi, T1
Ishibashi, N2
Ohkita, A1
Mizobe, T1
Ogo, S1
Ikeda, S1
Ozasa, H1
Shirouzu, K2
Kabashima, A1
Sakaguchi, Y1
Okita, K1
Yamamura, S1
Ojima, Y1
Nishizaki, T2
Tashiro, H1
Matsuzaka, T1
Toyokawa, A1
Tsujimura, T1
Hamabe, Y1
Sato, S1
Mukubou, H1
Wakahara, T1
Kaji, M1
Tsukamoto, T1
Wakita, K1
Onishi, N1
Watanabe, A1
Fujiwara, H1
Mukai, H1
Ito, T1
Mizuno, H1
Souma, Y1
Kainuma, S1
Yamanaka, H1
Ozawa, H1
Kanou, T1
Nakamori, Y1
Iwase, K1
Ogawa, T1
Makita, F1
Tanahashi, Y1
Ohya, T1
Tomizawa, N1
Satoh, Y1
Kobayashi, I1
Izumi, M1
Takeyoshi, I1
Hamada, K1
Minaguchi, S1
Togo, Y1
Toshihiko, T1
Koyama, T1
Kamio, M1
Sunagozaka, H1
Yamashita, T1
Kagaya, T1
Kato, Y1
Kaneko, S1
Inaba, Y1
Yamaura, H1
Shimamoto, H1
Nishiofuku, H1
Oyama, T1
Kanemitsu, Y1
Sawaki, A1
Arai, Y1
Muro, K1
Ijichi, M1
Matsuyama, Y1
Sano, K1
Sugawara, Y1
Kokudo, N1
Makuuchi, M1
Kawashima, M1
Hayashi, R1
Tahara, M1
Yamazaki, M1
Arahira, S1
Ogino, T1
Fukunaga, M1
Okamura, S1
Narahara, H1
Uedo, N1
Ishihara, R1
Furukawa, H1
Gotoh, M1
Takiuchi, H1
Isogai, A1
Nagaya, M1
Matsuoka, H1
Tsukikawa, S2
Kubota, S1
Akagi, Y1
Ushijima, M1
Murakami, H1
Fukushima, T1
Camci, C1
Sevinc, A1
Aslan, Y1
Kalender, ME1
Buyukberber, S1
Akiyama, J1
Sagara, Y1
Takeda, Y1
Itoh, S1
Konishi, Y1
Harauchi, D1
Shinoto, M1
Kunitomo, K1
Kuwashima, T1
Korematsu, H1
Tamura, T1
Yoshikawa, H1
Toyosaki, M1
Komi, N1
Ao, T1
Uchida, T1
Yokoyama, E1
Kawakami, T1
Adachi, K1
Mashimo, S1
Endo, T1
Koshiba, K1
Takenaka, K1
Korenaga, D1
Hiroshige, K1
Sugimachi, K3
Takano, S1
Moriguchi, M1
Seki, N2
Higaki, T1
Watanabe, Y1
Ito, Y1
Oishi, H1
Nakata, Y1
Kono, S1
Kiman, K1
Satomi, T1
Sakonji, M1
Nihei, M1
Tanaka, T1
Kimijima, I1
Abe, R1
Okuyama, T1
Furusawa, M1
Yamada, Y1
Washida, H1
Tozawa, K1
Honma, H1
Kang, K1
Kubota, Y1
Hosaka, M1
Fukushima, S1
Kondo, I2
Ogura, T1
Hiramatsu, Y1
Araki, H1
Nakagawa, A1
Nakagawa, M1
Kamiyama, Y1
Shirasaka, T1
Asano, M1
Yasuno, M1
Naito, S1
Kumazawa, J1
Omoto, T1
Iguchi, A1
Sagiyama, K1
Osada, Y1
Hiratsuka, Y1
Ogawa, M1
Kakegawa, T1
Tomita, M1
Nishimura, R1
Nagao, K1
Miyayama, H1
Baba, K1
Matsuoka, Y3
Yamashita, H1
Fukuda, M3
Higuchi, A1
Masuyama, S1
Uchino, S1
Nishino, H1
Tanaka, H1
Kanazawa, T1
Miyata, M1
Kitamura, K1
Vokes, EE2
Brockstein, BE1
Humerickhouse, R1
Haraf, DJ2
Meropol, NJ1
Sonnichsen, DS1
Birkhofer, MJ1
Ferreira, I1
Noel, D1
Humerickhouse, RA1
Dolan, ME1
Brockstein, B1
Stenson, K1
Kies, M1
Sulzen, L1
Ratain, MJ1
González Barón, M1
Nakayama, Y1
Ogata, H1
Shimizu, K1
Nishikawa, T1
Adachi, Y1
Fukuma, E1
Hata, Y1
Uchino, J1
Asaishi, K1
Kubo, Y1
Mito, M1
Tanabe, T1
Ogita, M1
Hirata, K1
Schiebe, M1
Dethling, J1
Martin, C1
Watanabe, H2
Ohishi, T1
Abe, M1
Sumi, S1
Tamura, K1
Kohno, N1
Kitahara, S1
Kawaida, M1
Ohmuma, T1
Kusama, M1
Kaise, H1
Nakayama, S1
Oota, D1
Shimizu, H1
Koyanagi, Y1
Knowling, M1
Browman, G1
Siu, L1
Khoo, K1
Cooke, A1
Tannock, I1
Klaassen, D1
Cripps, C1
Goss, G1
Matthews, S1
Clarke, R1
Seymour, L1
Chakrapee-Sirisuk, S1
Sinlarat, P1
Lohsiriwat, D1
Lert-Akayamanee, N1
Nimmanwudipong, T1
Srimuninnimit, V1
Vathanophas, V1
Arch-Yaemsuan, P1
Boonnuch, W1
Yoshida, O1
Kakehi, Y1
Nishio, Y1
Tomoyoshi, T1
Konami, T1
Usui, T1
Igawa, M1
Takenaka, I1
Fujita, K1
Masuda, F2
Nakada, J1
Hirao, Y1
Okajima, E1
Ozono, S1
Samma, S1
Hiramatsu, T1
Babaya, K1
Watanabe, S1
Maruyama, Y1
Okuda, T1
Onda, M1
Tokunaga, A1
Teramoto, T1
Fujita, I1
Mizutani, T1
Kiyama, T1
Nishi, K1
Okazaki, S1
Kyono, S1
Moreira, LF1
Iwagaki, H1
Hizuta, A1
Sakagami, K1
Mimura, H1
Orita, K1
Taguchi, H1
Takaoka, K1
Mori, Y1
Torii, S1
Kobari, T1
Hosobe, T1
Namatame, K1
Sasaki, E1
Koh, Y1
Shimada, K1
Nakamura, T2
Hirose, T1
Ookubo, M1
Nakayoshi, A1
Iwashige, H1
Yamada, K1
Mure, H1
Maenohara, S1
Takao, S1
Ishizawa, T1
Shimazu, H1
Sato, K1
Kayama, T1
Sakurai, Y1
Ogawa, A1
Wada, T1
Sekiguchi, I1
Suzuki, M1
Aida, I1
Tamada, T1
Nishida, M1
Naito, K1
Hisazumi, H1
Saka, A1
Kanda, S1
Mikawa, I1
Ejiri, S1
Miyagi, T1
Katsumi, T1
Kitagawa, K1
Fujita, Y1
Ota, J1
Fujita, M1
Sugimoto, T1
Taguchi, T1
Kawano, N1
Moriya, Y1
Houjo, K1
Komoriyama, H1
Imaki, S1
Morikubo, M1
Asakura, T1
Okamura, R1
Kanasugi, K1
Oda, H1
Nabeshima, S1
Oda, T1
Nishio, S1
Iwata, H1
Takeuchi, M1
Matsumoto, A1
Terado, T1
Deguchi, S1
Kurihara, K1
Hokama, A1
Muto, Y1
Toda, T1
Tsuji, H2
Tsujii, H2
Kamada, T2
Takamura, A2
Shirato, H1
Irie, G2
Aoki, Y1
Tabuse, Y1
Tanimura, H1
Katsumi, M1
Asae, M1
Ichimiya, G1
Imai, T1
Ooshima, K1
Kakihara, M1
Kashitani, M1
Usubuchi, H1
Yasutake, K1
Imamura, Y1
Yoshimura, Y1
Oya, M1
Matsushita, K1
Hozumi, T1
Katou, J1
Okutani, T1
Irie, K1
Takatsuka, Y1
Nakayama, H1
Kawahara, T1
Ohyama, S1
Yonemura, Y1
Matsuki, N1
Miyata, R1
Noto, H1
Sakuma, H1
Yagi, M1
Sawa, T1
Ogino, S1
Miyazaka, I1
Nasu, K1
Nakarai, I1
Horiuchi, M1
Shinoda, A1
Mardakhiashvili, ShI1

Clinical Trials (9)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomized, Controlled Phase II Clinical Trial of Fruquintinib Combined With Raltitrexed Versus Fruquintinib Monotherapy in Patients With Advanced Colorectal Cancer Who Had Failed Second-line or Above Standard Chemotherapy[NCT04582981]Phase 2136 participants (Anticipated)Interventional2020-09-28Recruiting
Randomized Phase III Trial of Adjuvant Chemotherapy With UFT vs. Observation in Curatively Resected Stage II Colon Cancer[NCT00392899]Phase 32,025 participants (Actual)Interventional2006-10-31Completed
1922GCCC: PHASE 2 STUDY OF PEMBROLIZUMAB AND BAVITUXIMAB FOR PROGRESSIVE RECURRENT/METASTATIC SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK[NCT04150900]Phase 27 participants (Actual)Interventional2020-01-13Active, not recruiting
Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase 3, Multicentre, Randomised Controlled Trial (CAN)[NCT02958111]Phase 3406 participants (Actual)Interventional2017-01-31Active, not recruiting
Randomized, Placebo-controlled, Double-blind Phase II Clinical Trial of Neoadjuvant and Adjuvant Anti-PD-1 Antibody Toripalimab Immunotherapy Combined With Concurrent Chemoradiotherapy for High-risk Nasopharyngeal Carcinoma[NCT03925090]Phase 2150 participants (Anticipated)Interventional2019-12-08Active, not recruiting
Phase Ⅲ Trial of Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy (GP Versus PF) in Patients With N2-3 Nasopharyngeal Carcinoma[NCT03321539]Phase 3216 participants (Anticipated)Interventional2017-10-30Active, not recruiting
A Phase Ib/II Study of Ramucirumab (Cyramza®), Nal-IRI (ONIVYDE®) and Trifluridine/Tipiracil (Lonsurf®) in Second Line Metastatic Gastric Cancer (COOL Study).[NCT05927857]Phase 1/Phase 245 participants (Anticipated)Interventional2023-09-01Not yet recruiting
Aspirin/Folate Prevention of Large Bowel Polyps[NCT00272324]Phase 2/Phase 31,121 participants Interventional1992-02-29Completed
A Randomized Controlled Phase III Adjuvant Trial of High-Dose Bolus IL-2 in Patients With High-Risk Renal Cell Carcinoma[NCT00003126]Phase 369 participants (Actual)Interventional1997-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

7 reviews available for uracil and Local Neoplasm Recurrence

ArticleYear
Beyond second-line therapy in patients with metastatic colorectal cancer: a systematic review.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2018, 04-01, Volume: 29, Issue:4

    Topics: Colorectal Neoplasms; Disease Progression; Drug Combinations; Drugs, Investigational; Humans; Neopla

2018
[Recent advance in adjuvant therapy for breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:13

    Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; C

2002
[Complete disappearance with oral UFT administration of recurrent hepatocellular carcinoma of the remnant liver and multiple lung metastasis after hepatic resection].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:9

    Topics: Administration, Oral; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers

2003
[Effect of systemic chemotherapy by 5-FU with low dose CDDP (in the hospital) and UFT with low dose CDDP (in outpatient clinic) in unresectable recurrent colorectal cancer].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 7

    Topics: Ambulatory Care Facilities; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Ne

2003
[Present status of chemotherapy for colorectal cancer in countries outside of Japan].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 7

    Topics: Administration, Oral; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Comb

2003
Oral 5-FU alternatives for the treatment of head and neck cancer.
    Oncology (Williston Park, N.Y.), 1998, Volume: 12, Issue:10 Suppl 7

    Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol

1998
[Oral fluoropyrimidines in oncology].
    Anales de la Real Academia Nacional de Medicina, 1998, Volume: 115, Issue:3

    Topics: Administration, Oral; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplas

1998

Trials

49 trials available for uracil and Local Neoplasm Recurrence

ArticleYear
Prospective observational study of the efficacy of oral uracil and tegafur plus leucovorin for stage II colon cancer with risk factors for recurrence using propensity score matching (JFMC46-1201).
    BMC cancer, 2022, Feb-15, Volume: 22, Issue:1

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols

2022
TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial.
    The Lancet. Oncology, 2020, Volume: 21, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colorectal Neoplasms; Drug Combin

2020
A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur-uracil versus surgery alone in stage II colon cancer: SACURA trial.
    European journal of cancer (Oxford, England : 1990), 2018, Volume: 96

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols

2018
Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019, 08-01, Volume: 37, Issue:22

    Topics: Aged; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Epithelial-Mesenchymal Trans

2019
Treatment Rationale and Study Design for Clinical Trial on the Efficacy of UFT/LV for Stage II Colorectal Cancer With Risk Factors for Recurrence (JFMC46-1201).
    Clinical colorectal cancer, 2015, Volume: 14, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Humans

2015
Administration of adjuvant oral tegafur/uracil chemotherapy post hepatocellular carcinoma resection: A randomized controlled trial.
    Asian journal of surgery, 2016, Volume: 39, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemot

2016
A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2016
Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/II Clinical Study.
    The oncologist, 2016, Volume: 21, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell;

2016
Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: a non-randomized phase II study.
    Lung cancer (Amsterdam, Netherlands), 2009, Volume: 66, Issue:3

    Topics: Administration, Oral; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small

2009
High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
    Acta oncologica (Stockholm, Sweden), 2012, Volume: 51, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Feas

2012
Phase I clinical trial of a peptide vaccine combined with tegafur-uracil plus leucovorin for treatment of advanced or recurrent colorectal cancer.
    Oncology reports, 2013, Volume: 29, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Colorectal Neoplasms;

2013
Retrospective study on thymidylate synthase as a predictor of outcome and sensitivity to adjuvant chemotherapy in patients with curatively resected colorectal cancer.
    Anti-cancer drugs, 2002, Volume: 13, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Colorecta

2002
Phase I study of oral uracil and Tegafur plus leucovorin and pelvic radiation in patients with recurrent rectal cancer.
    Anti-cancer drugs, 2002, Volume: 13, Issue:10

    Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therap

2002
[Hepatic recurrence after prophylactic hepatic arterial infusion of 5-fluorouracil for Dukes' C colorectal cancer--correlation with the expression of dihydropyrimidine dehydrogenase in the primary tumor].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:12

    Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol

2002
Adjuvant therapy with protein-bound polysaccharide K and tegafur uracil in patients with stage II or III colorectal cancer: randomized, controlled trial.
    Diseases of the colon and rectum, 2003, Volume: 46, Issue:8

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; C

2003
[Phase I study of gemcitabine (GEM) and UFT combination chemotherapy for unresectable/recurrent pancreatic cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administration Schedule; D

2004
A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon.
    International journal of radiation oncology, biology, physics, 2004, Mar-01, Volume: 58, Issue:3

    Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplasti

2004
[Clinical usefulness of UFT and cyclophosphamide as salvage chemotherapy for patients with metastatic breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:5

    Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols;

2004
Phase II study on low dose gemcitabine plus oral chemotherapy with uracil-tegafur and cyclophosphamide in combination with radiotherapy against recurrent and advanced pancreatic cancer.
    Oncology reports, 2005, Volume: 14, Issue:2

    Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therap

2005
High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: a phase I trial.
    Acta oncologica (Stockholm, Sweden), 2005, Volume: 44, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic

2005
Beneficial effects of protein-bound polysaccharide K plus tegafur/uracil in patients with stage II or III colorectal cancer: analysis of immunological parameters.
    Oncology reports, 2006, Volume: 15, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CD11b Antigen; CD57 Antigens; CD8 Antig

2006
Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial.
    Hepatology (Baltimore, Md.), 2006, Volume: 44, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy

2006
Phase I/II study of CPT-11 plus UFT in patients with advanced/recurrent colorectal cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG): Protocol 0102.
    Japanese journal of clinical oncology, 2007, Volume: 37, Issue:7

    Topics: Adenocarcinoma; Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; An

2007
An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
    Surgery, 2007, Volume: 142, Issue:5

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Colorectal Neoplasms; Combined Modalit

2007
[Clinical trial of UFT against disseminated breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1984, Volume: 11, Issue:11

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms;

1984
[Prophylactic combination therapy after TUR of superficial bladder cancer].
    Hinyokika kiyo. Acta urologica Japonica, 1993, Volume: 39, Issue:11

    Topics: Administration, Intravesical; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic C

1993
[The significance of portal infusion chemotherapy for prevention of recurrence in residual liver after hepatectomy for metastases from colorectal cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:13

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; He

1994
[Efficacy of combination therapy consisting of cyclophosphamide, adriamycin, UFT and oophorectomy/tamoxifen for advanced or recurrent breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph

1994
Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion.
    American journal of surgery, 1994, Volume: 168, Issue:1

    Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modali

1994
Prophylactic oral UFT therapy for superficial bladder cancer.
    Cancer, 1993, Mar-01, Volume: 71, Issue:5

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols

1993
[Combined chemotherapy with 5-FU and low dose CDDP for advanced or recurrent cancer of the digestive system and home anti-cancer chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22 Suppl 4

    Topics: Administration, Oral; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy,

1995
[Low-dose cisplatin added to continuous infusion of 5-fluorouracil or oral administration of UFT for inoperable advanced or recurrent colorectal cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:1

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Coloni

1997
Postoperative UFT adjuvant and the risk factors for recurrence in renal cell carcinoma: a long-term follow-up study. Kyushu University Urological Oncology Group.
    International journal of urology : official journal of the Japanese Urological Association, 1997, Volume: 4, Issue:1

    Topics: Antimetabolites, Antineoplastic; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Drug Combinations; F

1997
Dose intensity of uracil and tegafur in postoperative chemotherapy for patients with poorly differentiated gastric cancer.
    Cancer chemotherapy and pharmacology, 1997, Volume: 40, Issue:3

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Diseas

1997
Postoperative adjuvant chemotherapy with mitomycin C and UFT for rectal cancer.
    Oncology (Williston Park, N.Y.), 1997, Volume: 11, Issue:9 Suppl 10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Combinatio

1997
Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer.
    Cancer chemotherapy and pharmacology, 1999, Volume: 43, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bi

1999
Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:2

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combin

1999
UFT and mitomycin plus tamoxifen for stage II, ER-positive breast cancer. Hokkaido ACETBC Study Group.
    Oncology (Williston Park, N.Y.), 1999, Volume: 13, Issue:7 Suppl 3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Di

1999
UFT plus calcium folinate plus radiotherapy for recurrent rectal cancer.
    Oncology (Williston Park, N.Y.), 1999, Volume: 13, Issue:7 Suppl 3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Follow-Up Studies; Humans; Leucovorin; Neoplasm Recu

1999
Prognosis after salvage chemotherapy for locally unresectable recurrent squamous cell carcinoma of the head and neck.
    Japanese journal of clinical oncology, 1999, Volume: 29, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dr

1999
A National Cancer Institute of Canada clinical trials group phase II study of eniluracil (776C85) and oral 5-fluorouracil in patients with advanced squamous cell head and neck cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:7

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Canada

2001
Uracil with ftorafur and low dose oral folinic acid in advanced colorectal cancer.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2001, Volume: 84, Issue:8

    Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Diarrhea;

2001
[Prophylactic effect of UFT in combination with intravesical chemotherapy on the recurrence of superficial bladder tumor].
    Hinyokika kiyo. Acta urologica Japonica, 1992, Volume: 38, Issue:12

    Topics: Administration, Intravesical; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic C

1992
Adjuvant chemotherapy with vinblastine, adriamycin, and UFT for renal-cell carcinoma.
    Cancer chemotherapy and pharmacology, 1992, Volume: 30, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Chemotherapy, Ad

1992
A prospective randomized study of prophylaxis of tumor recurrence following transurethral resection of superficial bladder cancer--intravesical thio-TEPA versus oral UFT.
    Cancer chemotherapy and pharmacology, 1992, Volume: 30 Suppl

    Topics: Administration, Intravesical; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Proto

1992
[A comparative clinical trial of UFT treatment and intravesical adriamycin instillation to prevent recurrence of superficial bladder cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:4

    Topics: Administration, Intravesical; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols;

1992
[Prophylactic effect of UFT on the recurrence of bladder cancer].
    Hinyokika kiyo. Acta urologica Japonica, 1990, Volume: 36, Issue:4

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols

1990
[A comparative clinical trial of UFT medication and intravesical BCG in the recurrence of superficial bladder cancer. Study Group of UFT and BCG adjuvant therapy for bladder cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:10

    Topics: Administration, Intravesical; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined

1990
[Clinical effect of combined chemotherapy with UFT, MMC and OK-432 in recurring or advanced cancer of the digestive organs].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Digestive System Neo

1989

Other Studies

89 other studies available for uracil and Local Neoplasm Recurrence

ArticleYear
Initial experience of TAS-102 chemotherapy in Australian patients with Chemo-refractory metastatic colorectal cancer.
    Current problems in cancer, 2022, Volume: 46, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Australia; Colonic Neoplasms; Colorectal Neoplasms;

2022
Impact of thoracic esophageal displacement after lobectomy on the continuity of oral adjuvant chemotherapy.
    Asian cardiovascular & thoracic annals, 2022, Volume: 30, Issue:5

    Topics: Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chem

2022
Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer.
    PloS one, 2022, Volume: 17, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colorectal Neoplasms; Humans; Neoplasm

2022
N2 Lymph Node Metastasis Is a Useful Predictor of Recurrence in Patients With Stage III Rectal Cancer Undergoing Adjuvant Chemotherapy Using Tegafur-uracil/leucovorin.
    Anticancer research, 2023, Volume: 43, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Humans

2023
Prognostic factors in refractory metastatic colorectal cancer patients treated with Trifluridine/Tipiracil.
    Journal of cancer research and clinical oncology, 2023, Volume: 149, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Colorectal Neoplasms; Drug Combin

2023
Oral uracil-tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients.
    Cancer medicine, 2023, Volume: 12, Issue:17

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuva

2023
Metronomic chemotherapy with tegafur-uracil following radical resection in stage II colorectal cancer.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2021, Volume: 120, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms;

2021
[Long-Term Survivor with Recurrent Gastric Cancer Using Trifluridine/Tipiracil as a Late-Line Chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2020, Volume: 47, Issue:13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Combinations; Humans; Neo

2020
[Two Cases of Metastatic Colorectal Cancer Treated with TAS-102 plus Bevacizumab].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2021, Volume: 48, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colorectal Neoplasms; Drug Combinations

2021
Severe neutropenia: a prognosticator in patients with advanced/recurrent colorectal cancer
    Die Pharmazie, 2017, Jan-10, Volume: 72, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherap

2017
Risk factors contributing to the development of neutropenia in patients receiving oral trifluridine-tipiracil (TAS-102) chemotherapy for advanced/recurrent colorectal cancer.
    Die Pharmazie, 2018, 03-05, Volume: 73, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Creatinine; Drug Combinations; Female; Humans;

2018
Identification of Predictors of Recurrence in Patients with Lower Rectal Cancer Undergoing Neoadjuvant Chemotherapy: A Direct Comparison of Short-Course and Long-Course Chemoradiotherapy.
    Oncology, 2019, Volume: 96, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; C

2019
Toxicity and Efficacy of Sequential Chemotherapy in Patients with p-stage I Non-small Cell Lung Cancer that Recurring during Postoperative Tegafur-Uracil Adjuvant Chemotherapy.
    Cancer investigation, 2018, Volume: 36, Issue:8

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell L

2018
[A Case of Spontaneous Esophageal Rupture That Required Operation during Adjuvant Chemotherapy for Transverse Colon Cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:13

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colon, Transverse; Col

2018
Evaluation of Tolerability of Trifluridine/Tipiracil Combination Tablet in Patients With Advanced/Recurrent Colorectal Cancer.
    Anticancer research, 2019, Volume: 39, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Co

2019
Recurrence rate of hepatocellular carcinoma in patients with treated hepatocellular carcinoma and hepatitis C virus-associated cirrhosis after ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin therapy.
    United European gastroenterology journal, 2019, Volume: 7, Issue:5

    Topics: 2-Naphthylamine; Aged; Anilides; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Chemoembol

2019
CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer.
    Annals of surgical oncology, 2014, Volume: 21 Suppl 3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; CD8-Positive T-Lymphocytes; Chemoradiotherapy;

2014
Antitumor activity of 7-aminocarboxycoumarin derivatives, a new class of potent inhibitors of lactate influx but not efflux.
    Molecular cancer therapeutics, 2014, Volume: 13, Issue:6

    Topics: Animals; Breast Neoplasms; Colorectal Neoplasms; Coumarins; Female; HCT116 Cells; Humans; Lactic Aci

2014
Repeat hepatectomy for intrahepatic recurrence of cholangiolocellular carcinoma.
    Fukuoka igaku zasshi = Hukuoka acta medica, 2013, Volume: 104, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic;

2013
Metronomic adjuvant chemotherapy improves treatment outcome in nasopharyngeal carcinoma patients with postradiation persistently detectable plasma Epstein-Barr virus deoxyribonucleic acid.
    International journal of radiation oncology, biology, physics, 2014, May-01, Volume: 89, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Chemotherapy, Adjuvant; Cisplatin

2014
Metronomic adjuvant chemotherapy improves treatment outcome in nasopharyngeal carcinoma patients with postradiation persistently detectable plasma Epstein-Barr virus deoxyribonucleic acid.
    International journal of radiation oncology, biology, physics, 2014, May-01, Volume: 89, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Chemotherapy, Adjuvant; Cisplatin

2014
Metronomic adjuvant chemotherapy improves treatment outcome in nasopharyngeal carcinoma patients with postradiation persistently detectable plasma Epstein-Barr virus deoxyribonucleic acid.
    International journal of radiation oncology, biology, physics, 2014, May-01, Volume: 89, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Chemotherapy, Adjuvant; Cisplatin

2014
Metronomic adjuvant chemotherapy improves treatment outcome in nasopharyngeal carcinoma patients with postradiation persistently detectable plasma Epstein-Barr virus deoxyribonucleic acid.
    International journal of radiation oncology, biology, physics, 2014, May-01, Volume: 89, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Chemotherapy, Adjuvant; Cisplatin

2014
Metronomic adjuvant chemotherapy improves treatment outcome in nasopharyngeal carcinoma patients with postradiation persistently detectable plasma Epstein-Barr virus deoxyribonucleic acid.
    International journal of radiation oncology, biology, physics, 2014, May-01, Volume: 89, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Chemotherapy, Adjuvant; Cisplatin

2014
Metronomic adjuvant chemotherapy improves treatment outcome in nasopharyngeal carcinoma patients with postradiation persistently detectable plasma Epstein-Barr virus deoxyribonucleic acid.
    International journal of radiation oncology, biology, physics, 2014, May-01, Volume: 89, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Chemotherapy, Adjuvant; Cisplatin

2014
Metronomic adjuvant chemotherapy improves treatment outcome in nasopharyngeal carcinoma patients with postradiation persistently detectable plasma Epstein-Barr virus deoxyribonucleic acid.
    International journal of radiation oncology, biology, physics, 2014, May-01, Volume: 89, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Chemotherapy, Adjuvant; Cisplatin

2014
Metronomic adjuvant chemotherapy improves treatment outcome in nasopharyngeal carcinoma patients with postradiation persistently detectable plasma Epstein-Barr virus deoxyribonucleic acid.
    International journal of radiation oncology, biology, physics, 2014, May-01, Volume: 89, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Chemotherapy, Adjuvant; Cisplatin

2014
Metronomic adjuvant chemotherapy improves treatment outcome in nasopharyngeal carcinoma patients with postradiation persistently detectable plasma Epstein-Barr virus deoxyribonucleic acid.
    International journal of radiation oncology, biology, physics, 2014, May-01, Volume: 89, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Chemotherapy, Adjuvant; Cisplatin

2014
Inferior oncological prognosis of surgery without oral chemotherapy for stage III colon cancer in clinical settings.
    World journal of surgical oncology, 2014, May-10, Volume: 12

    Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemot

2014
Multicenter observational cohort study of post-operative treatment for completely resected non-small-cell lung cancer of pathological Stage I (T1 >2 cm and T2 in TNM classification version 6).
    Japanese journal of clinical oncology, 2015, Volume: 45, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuva

2015
Volume-reserving Surgery after Photodynamic Therapy for Biliary Papillomatosis: A Case Report.
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2015, Volume: 66, Issue:1

    Topics: Antineoplastic Agents; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Embolization, Therapeutic; Gam

2015
Emerging phase 3 data in relapsed/refractory metastatic colorectal cancer.
    Clinical advances in hematology & oncology : H&O, 2016, Volume: 14, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Colorectal Neop

2016
Safety of an oral anticancer agent (trifluridine/tipiracil combination tablet) in patients with advanced and recurrent colorectal cancer.
    Die Pharmazie, 2016, Volume: 71, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Drug Combinations; Female;

2016
[A Case of Primary Acinic Cell Carcinoma(ACC)of the Breast].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Acinar Cell; Chemothera

2016
Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort.
    Journal of hepatology, 2017, Volume: 66, Issue:6

    Topics: 2-Naphthylamine; Adult; Aged; Aged, 80 and over; Anilides; Antiviral Agents; Benzimidazoles; Carbama

2017
Retrospective analysis of surgical resection after induction chemotherapy for patients with T4b squamous cell head and neck cancer.
    Acta oncologica (Stockholm, Sweden), 2008, Volume: 47, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell;

2008
[Two cases of squamous cell carcinoma of upper urinary tract with hypercalcemia].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2008, Volume: 99, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modali

2008
[Two cases of advanced hepatocellular carcinoma (HCC) effectively treated by oral UFT administration].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:11

    Topics: Administration, Oral; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carc

2008
[Three cases of complete response after treatment with UFT and leucovorin for recurrent colorectal cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Colorectal Ne

2008
Efficacy of postoperative UFT (Tegafur/Uracil) plus PSK therapies in elderly patients with resected colorectal cancer.
    Cancer biotherapy & radiopharmaceuticals, 2009, Volume: 24, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therap

2009
[Local recurrence after surgical resection of pancreatic cancer effectively treated with combined chemoradiotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:6

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bio

2009
Postoperative chemotherapy after neoadjuvant chemoradiation and surgery for rectal cancer: is it essential for patients with ypT0-2N0?
    Journal of surgical oncology, 2009, Oct-01, Volume: 100, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuv

2009
Complete remission of multiple recurrent hepatocellular carcinomas by oral administration of enteric-coated tegafur/uracil in a patient with huge hepatocellular carcinoma extending to the inferior vena cava after hepatic resection: analysis of mRNA expres
    International journal of clinical oncology, 2009, Volume: 14, Issue:3

    Topics: Administration, Oral; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality T

2009
Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.
    Annals of surgical oncology, 2009, Volume: 16, Issue:12

    Topics: AC133 Antigen; Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers

2009
Placement of an expandable metallic stent improves the efficacy of chemoradiotherapy for pancreatic cancer with malignant portal vein stenosis or obstruction.
    Anticancer research, 2009, Volume: 29, Issue:8

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Con

2009
The necessity of chemotherapy in T3N0M0 colon cancer without risk factors.
    American journal of surgery, 2009, Volume: 198, Issue:3

    Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Col

2009
Can the 2-(13)C-uracil breath test be used to predict the effect of the antitumor drug S-1?
    Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:2

    Topics: Aged; Aged, 80 and over; Alleles; Antineoplastic Combined Chemotherapy Protocols; Aryl Hydrocarbon H

2010
Uracil misincorporation into DNA and folic acid supplementation.
    The American journal of clinical nutrition, 2010, Volume: 91, Issue:1

    Topics: Adenoma; Aged; Alcohol Drinking; Aspirin; Colonoscopy; Colorectal Neoplasms; Dietary Supplements; DN

2010
[A case report of combined hepatocellular-cholangiocarcinoma whose lymph node recurrence effectively treated with UFT].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:12

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neo

2009
The impact of preoperative chemoradiotherapy on advanced low rectal cancer.
    Journal of surgical oncology, 2010, Dec-01, Volume: 102, Issue:7

    Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Combined Modal

2010
[A case of recurrent sigmoid colon cancer with adrenal and para-aortic lymph node metastasis successfully treated by operation and chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:12

    Topics: Adrenal Gland Neoplasms; Adrenalectomy; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies,

2010
[An experience of curative resection of local recurrent rectal cancer with high-level sacrectomy after preoperative chemo-radiation therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Com

2010
[A case of local relapsed rectal cancer responding to low-dose S-1].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:12

    Topics: Administration, Oral; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Ch

2010
[A case of salvage treatment for local recurrence of squamous cell anal carcinoma after chemoradiation].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Comb

2010
[A long-term survival case of local recurrence of breast cancer treated with combined modality therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:12

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; An

2010
[Simultaneous detection of both non-Hodgkin's lymphoma cells and breast cancer cells in pleural effusion--a case report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:10

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide;

2003
[A case of hepatic metastasis and local recurrence from rectal cancer responding to hepatic arterial infusion and systemic chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:11

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administrat

2003
Preoperative radio/chemo-radiotherapy in combination with intraoperative radiotherapy for T3-4Nx rectal cancer.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2004, Volume: 30, Issue:7

    Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Agents; Cohort Studies; Combined Modality Thera

2004
Uracil-tegafur in early-stage lung cancer.
    The New England journal of medicine, 2004, Aug-12, Volume: 351, Issue:7

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Humans; Lung

2004
Spontaneous regression of recurrent squamous cell carcinoma of the tongue.
    International journal of clinical oncology, 2004, Volume: 9, Issue:4

    Topics: Aged; Carcinoma, Squamous Cell; Drug Combinations; Humans; Male; Neoplasm Recurrence, Local; Neoplas

2004
[A case of long-term survivor with multiple pulmonary metastases of HCC after hepatic resection].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Drug Combinati

2004
The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
    Cancer chemotherapy and pharmacology, 2006, Volume: 57, Issue:5

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemo

2006
[Efficacy of tegafur/uracil plus oral leucovorin therapy for advanced or recurrent colorectal cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:12

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms

2005
[Clinical study of ambulatory patient cancer chemotherapy for advanced colorectal cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:13

    Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols;

2005
[A case of recurrent colon cancer responding completely to uracil/tegafur (UFT) plus oral leucovorin (LV) therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:13

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colonic Neoplasms;

2005
[A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administration Schedule; Drug Co

2006
[Retrospective analysis of tegafur/uracil (UFT) plus oral leucovorin (LV) regimen in patients with advanced colorectal cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:7

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols

2006
Accelerated radiotherapy and larynx preservation in favorable-risk patients with T2 or worse hypopharyngeal cancer.
    Japanese journal of clinical oncology, 2007, Volume: 37, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Follow-Up Studies; Humans; Hypophar

2007
Metronomic chemotherapy using weekly low-dosage CPT-11 and UFT as postoperative adjuvant therapy in colorectal cancer at high risk to recurrence.
    Journal of experimental & clinical cancer research : CR, 2007, Volume: 26, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Com

2007
Complete remission of platinium refractory ovarian cancer with second line tegafur with uracil monotherapy: a case report.
    Cancer chemotherapy and pharmacology, 2009, Volume: 63, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Combined Modality Therapy; Cys

2009
[Effective cases of advanced endometrial and recurrent ovarian cancers treated with oral administration of UFT].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1984, Volume: 11, Issue:3

    Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Tra

1984
[Clinical trial of UFT in recurrent or advanced cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1982, Volume: 9, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasm

1982
Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma.
    American journal of surgery, 1995, Volume: 169, Issue:4

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Che

1995
[Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer].
    Hinyokika kiyo. Acta urologica Japonica, 1994, Volume: 40, Issue:7

    Topics: Administration, Intravesical; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols;

1994
[Prognostic effect of PyNPase (pyrimidine nucleoside phosphorylase) activity in breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dr

1998
[Combined chemotherapy with low-dose cisplatin, tegafur and uracil in a case with neck recurrence of laryngeal cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modali

1998
Combination therapy for advanced breast cancer: cyclophosphamide, doxorubicin, UFT, and tamoxifen.
    Oncology (Williston Park, N.Y.), 1999, Volume: 13, Issue:7 Suppl 3

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brea

1999
[A case of recurrent ampullary carcinoma of the papilla of Vater, in which a complete response was induced by combination therapy using radiotherapy and oral chemotherapy employing UFT and cyclophosphamide].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:11

    Topics: Administration, Oral; Adult; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Combi

1999
[A case of breast cancer with multiple metastases successfully treated by medroxyprogesterone acetate with intermittent intra-arterial infusion low-dose chemotherapy to hepatic metastasis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:14

    Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bre

2000
[Sharp decline in plasma CEA and reduction of liver metastasis after UFT administration in a patient with recurrent gastric cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:12

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoembr

1992
Can cytokines prolong survival in ampullary neuroendocrine carcinomas?
    The American journal of gastroenterology, 1992, Volume: 87, Issue:12

    Topics: Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Combined Modality Thera

1992
[A case of renal cell carcinoma with lung metastasis and local recurrence effectively treated with nephrectomy and UFT].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:14

    Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; C

1992
[Combination therapy with 5-FU, etoposide and CDDP (FEP regimen) in advanced primary and recurrent gastric cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule

1992
[A case of local recurrence of rectal cancer successfully treated by UFT combined with two-route CDDP chemotherapy under the AT-II induced hypertension].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:4

    Topics: Adenocarcinoma; Administration, Oral; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols

1991
[A case of recurrence of a metastatic brain tumor which disappeared due to chemotherapy only].
    No shinkei geka. Neurological surgery, 1990, Volume: 18, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Renal Cell; Humans; Kidn

1990
[Responsiveness of gynecological malignancies to oral antitumor agents in subrenal capsule assay and individualization of oral adjuvant chemotherapy].
    Nihon Sanka Fujinka Gakkai zasshi, 1990, Volume: 42, Issue:5

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols

1990
[Evaluation of subselective intraarterial infusion chemotherapy in advanced gastric cancer and recurrence case-evaluated on factors other than direct effects].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:8 Pt 2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedu

1990
[Results of prophylactic intra-arterial infusion chemotherapy after hepatic resection in colorectal metastases].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:8 Pt 2

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorour

1990
[UFT-MT therapy in advanced or recurrent breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Middl

1990
[A case of local recurrent breast cancer with complete response to combination of systemic chemotherapy and topical use of adriamycin ointment].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:11

    Topics: Administration, Topical; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin

1990
[Combined chemotherapy and radiotherapy in recurrent tumors of the head and neck region].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami

1987
Improved results in the treatment of nasopharyngeal carcinoma using combined radiotherapy and chemotherapy.
    Cancer, 1989, May-01, Volume: 63, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma,

1989
[Vincristine, adriamycin, mitomycin-C and UFT (VAM-UFT) therapy in progressive or recurrent breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Adm

1989
[Combination chemotherapy using low-dose epirubicin and vindesine in patients with metastatic breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:4 Pt 1

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms;

1988
[PMU therapy of recurrent gastric cancer. A case report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:3 Pt 1

    Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen;

1986
[Clinical study of combination chemotherapy using carboquone, cisplatin, UFT and OK-432 in 7 cases of advanced gastric cancers and a relapsed gastric cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:8 Pt 2

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carbazilquinone;

1988
[On the experimental prevention of recurrence and metastaais of malignant tumor with methacil and endoxan].
    Voprosy onkologii, 1967, Volume: 13, Issue:8

    Topics: Animals; Cyclophosphamide; Neoplasm Metastasis; Neoplasm Recurrence, Local; Rats; Sarcoma, Experimen

1967
chemdatabank.com